Cargando…
Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy
Despite recent advances in cancer research, glioblastoma multiforme (GBM) remains a highly aggressive brain tumor as its treatment options are limited. The current standard treatment includes surgery followed by radiotherapy and adjuvant chemotherapy. However, surgery without image guidance is often...
Autores principales: | Mander, Sunam, Naffouje, Samer A., Gao, Jin, Li, Weiguo, Christov, Konstantin, Green, Albert, Bongarzone, Ernesto R., Das Gupta, Tapas K., Yamada, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353713/ https://www.ncbi.nlm.nih.gov/pubmed/35936749 http://dx.doi.org/10.3389/fonc.2022.940001 |
Ejemplares similares
-
The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents
por: Mander, Sunam, et al.
Publicado: (2023) -
Image-guided surgery with a new tumour-targeting probe improves the identification of positive margins
por: Goto, Masahide, et al.
Publicado: (2022) -
Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression
por: Choi, Juliana K., et al.
Publicado: (2023) -
Tumor-Penetrating Peptides
por: Teesalu, Tambet, et al.
Publicado: (2013) -
p28 Bacterial Peptide, as an Anticancer Agent
por: Yaghoubi, Atieh, et al.
Publicado: (2020)